14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.07 $1.07 Wednesday, 6th Dec 2023 SURF stock ended at $1.07. During the day the stock fluctuated 0% from a day low at $1.07 to a day high of $1.07.
90 days $1.01 $1.09
52 weeks $0.555 $1.12

Historical Surface Oncology Inc. prices

Date Open High Low Close Volume
Dec 06, 2023 $1.07 $1.07 $1.07 $1.07 0
Dec 05, 2023 $1.07 $1.07 $1.07 $1.07 0
Dec 04, 2023 $1.07 $1.07 $1.07 $1.07 0
Dec 01, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 30, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 29, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 28, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 27, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 24, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 22, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 21, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 20, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 17, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 16, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 15, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 14, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 13, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 10, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 09, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 08, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 07, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 06, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 03, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 02, 2023 $1.07 $1.07 $1.07 $1.07 0
Nov 01, 2023 $1.07 $1.07 $1.07 $1.07 0
Click to get the best stock tips daily for free!

About Surface Oncology Inc.

Surface Oncology. Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine... SURF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT